Article may be outdated

This article is 10 days old. Some details may have changed since publication.

SMH.com.au·4 min read·medium

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

R
Rachel Rasker
‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s
✦AI Summary

Nutrition experts are raising concerns about the potential for malnutrition and muscle loss among patients using GLP-1 weight-loss drugs like Ozempic and Wegovy. Research from the University of Newcastle highlights a critical lack of data regarding the long-term health risks of rapid weight loss associated with these medications.

Why it matters

As GLP-1 usage surges, identifying and mitigating nutritional deficiencies is essential to prevent serious health complications like heart problems and brain damage.

✦Dive DeeperCreate a free account to unlock

Save You have reached your maximum number of saved items.

Remove items from your saved list to add more.

Gift Gift icon 0 / 3 No gift articles left

You've used all of your gift articles. 3 more will become available on the 1st of every month.

Share A A A Some of the millions of Australians expected to use Ozempic and other GLP-1s could run the risk of malnutrition and muscle loss, but the extent of these complications is not being tracked, nutrition experts warn.

There is a critical gap in evidence focused on the health hazards of rapid weight loss and GLP-1s (glucagon-like peptide-1 receptor agonists), new research from the University of Newcastle found. Extreme cases of malnutrition carry the risk of brain damage, heart problems and death.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in